RRC ID 85263
著者 Ogawa N, Seki A, Nasti A, Yagi H, Yamato M, Inui H, Nomura H, Komura T, Nakagawa H, Nio K, Takatori H, Shimakami T, Honda M, Kaneko S, Sakai Y, Yamashita T.
タイトル Therapeutic effects of adipose tissue-derived mesenchymal stem cells on ER stress in a murine model of metabolic dysfunction-associated steatohepatitis: an in vivo and in vitro study.
ジャーナル Stem Cell Res Ther
Abstract BACKGROUND:Metabolic dysfunction-associated fatty liver disease (MAFLD) is an increasing concern due to lifestyle changes, with metabolic dysfunction-associated steatohepatitis (MASH) leading to progressive liver damage, cirrhosis, and increased morbidity. The role of endoplasmic reticulum (ER) stress, particularly the unfolded protein response (UPR) pathway, in MASH progression remains unclear. Adipose tissue-derived stem cells (ADSCs) have shown promise in regenerative therapy; however, their mechanism for alleviating MASH-induced liver damage is not fully understood. In this study, we aimed to investigate the therapeutic mechanism of ADSCs in MASH, focusing on their modulation of ER stress in hepatocytes.
METHODS:C57BL/6J mice were fed either an atherogenic high-fat diet (AT + HF) or a high-fat diet (HFD-60) to induce MASH and simple steatosis (SS), respectively. Liver tissues were analyzed for gene expression, protein levels, and apoptotic markers using DNA microarray, quantitative PCR, western blotting, histological staining, and caspase activity assays. ADSCs were harvested, cultured, and treated to assess their effects on ER stress. In vitro experiments investigated palmitic acid-induced ER stress in hepatocytes and the effects of ADSCs on hepatic stellate cells and inflammatory markers.
RESULTS:The PERK arm of the UPR pathway was significantly upregulated in MASH liver tissues compared to SS tissues, correlating with increased apoptosis. ADSC administration reduced PERK activation, decreased apoptotic marker expression, and ameliorated hepatic fibrosis. However, ADSCs did not directly attenuate palmitic acid-induced ER stress in hepatocytes in vitro. Instead, they modulated the hepatic microenvironment by reducing hepatic stellate cell activation and IL-17-associated inflammation, indirectly mitigating ER stress and hepatocyte apoptosis.
CONCLUSIONS:ADSCs alleviate MASH progression by modulating ER stress via immunomodulation rather than through directly rescuing hepatocytes. These findings highlight the potential of ADSCs as an immunomodulatory therapeutic strategy for MASH and support further investigation into their clinical application.
巻・号 16(1)
ページ 349
公開日 2025-7-6
DOI 10.1186/s13287-025-04482-4
PII 10.1186/s13287-025-04482-4
PMID 40619419
PMC PMC12232772
MeSH Adipose Tissue* / cytology Animals Apoptosis Diet, High-Fat / adverse effects Disease Models, Animal Endoplasmic Reticulum Stress* Fatty Liver* / metabolism Fatty Liver* / pathology Fatty Liver* / therapy Hepatocytes / metabolism Male Mesenchymal Stem Cell Transplantation* Mesenchymal Stem Cells* / cytology Mesenchymal Stem Cells* / metabolism Mice Mice, Inbred C57BL Non-alcoholic Fatty Liver Disease / therapy Unfolded Protein Response
IF 5.116
リソース情報
ヒト・動物細胞 KUP5(RCB4627)